Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iloprost bridging therapy before heart transplantation in patients with pulmonary hypertension and left heart failure
2013-001613-33Phase 2Terminated
- Sponsor
- Thoraxklinik am Universitätsklinikum Heidelberg
- Start
- Nov 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of iloprost in pulmonary hypertension (PH) and Left Heart Failure, sponsored by Thoraxklinik am Universitätsklinikum Heidelberg. Primary endpoint: Change in pulmonary vascular resistance. Started Nov 2013; status: terminated.
02
Drugs
iloprost
03
Conditions
pulmonary hypertension (PH)Left Heart Failure
Beyond the preview
Go deeper on 2013-001613-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001613-33.